Trial intelligence / Profile preview

Colo-Pro_2: Cefuroxime Prophylaxis in Colorectal Surgery

NCT05609240Phase 2Recruiting

Sponsor
University of Leeds
Start
May 2023
Primary completion
May 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cefuroxime in surgical site infection (SSI), urinary tract infection (UTI), pneumonia, pyelonephritis, sponsored by University of Leeds. Started May 2023; status: recruiting.

02

Drugs

cefuroxime
03

Conditions

surgical site infection (SSI)urinary tract infection (UTI)pneumoniapyelonephritis

Beyond the preview

Go deeper on NCT05609240.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05609240.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call